Paper Details

  1. Home
  2. Paper Details

Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements.

Author: MuntjewerffN D, RamaekersJ G, RikkenG H, VuurmanE F P M, de HalleuxF

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Desloratadine, a non-sedating histamine H1-receptor antagonist, is presented as a safe alternative to first-generation antihistamines for allergic rhinitis. This study highlights the lack of sedation associated with desloratadine at therapeutic doses and its minimal impact on driving or psychomotor performance.
Paper Details　
Original Abstract of the Article :
First-generation antihistamines taken for relief of allergic rhinitis are sedating and pose potential risks for those driving a car or operating machinery. Desloratadine is a potent, selective, histamine H(1)-receptor antagonist that does not easily cross the blood-brain barrier. It is nonsedating a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00228-004-0757-9

データ提供：米国国立医学図書館（NLM）

Desloratadine: A Non-Sedating Antihistamine for Safe Driving

Allergic rhinitis, commonly known as hay fever, can be a nuisance, often causing symptoms like sneezing, runny nose, and itchy eyes. First-generation antihistamines, while effective in alleviating these symptoms, can often cause drowsiness, posing a risk for individuals engaged in activities requiring alertness, such as driving.

This study evaluates the effects of desloratadine, a newer generation antihistamine, on driving performance and psychomotor function. The researchers compared the effects of desloratadine, diphenhydramine (a first-generation antihistamine), and placebo on participants’ driving performance and psychomotor abilities. They found that desloratadine did not significantly affect driving performance or psychomotor function, suggesting that it is a non-sedating antihistamine.

Driving Safely with Desloratadine

The study offers a promising option for individuals with allergic rhinitis who require a non-sedating antihistamine. The findings suggest that desloratadine is safe for driving and other activities requiring alertness, providing a valuable alternative to first-generation antihistamines that can cause drowsiness.

Navigating the World of Antihistamines: A Guide for Safe and Effective Treatment

The study underscores the importance of selecting the appropriate antihistamine based on individual needs and lifestyle. For individuals who require a non-sedating option, desloratadine offers a safe and effective alternative. It’s always a good idea to consult with a healthcare professional to discuss the best treatment approach for your specific needs.

Dr. Camel's Conclusion

Like a camel navigating a winding path through a vast desert, finding the right antihistamine for your needs can be a journey. This study highlights the benefits of desloratadine as a non-sedating option, allowing individuals to navigate their daily lives with greater freedom and clarity. The study encourages us to be mindful of the potential side effects of medications and to choose those that best suit our individual needs.

Date :
  1. Date Completed 2004-11-08
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

15168099

DOI: Digital Object Identifier

10.1007/s00228-004-0757-9

Related Literature

Article Analysis
・Effects of desloratadine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.